
Analysts' Actions -- Abbott Labs, Garmin, Nordson, NetApp and More
RATINGS CHANGES
Abbott Labs (ABT) - Get Report was upgraded to buy at TheStreet Ratings. You can view the full analysis from the report here: ABT.
Garmin (GRMN) - Get Report was downgraded to sell from neutral at Goldman Sachs. $46 price target. Fitness segment growth is decelerating, Goldman said.
Jack Henry (JKHY) - Get Report was downgraded to perform from outperform at Oppenheimer. The valuation is less attractive, with shares trading at 28x earnings, Oppenheimer said.
Nordson (NDSN) - Get Report was downgraded to perform from outperform at Oppenheimer. The valuation is less attractive, with the stock trading at 20x expected 2017 earnings, Oppenheimer said.
NetApp (NTAP) - Get Report was upgraded to neutral from sell at Goldman Sacks. $32 price target. The valuation is more attractive, as revenue appears to be stabilizing, Goldman said.
Sanofi (SNY) - Get Report was downgraded to hold at TheStreet Ratings. You can view the full analysis from the report here: SNY.
Tutor Perini (TPC) - Get Report was upgraded to buy from neutral at MKM Partners. $28 price target. The company will likely pay down a significant amount of debt in the coming quarters and see a larger project pipeline, MKM said.
This article was written by a staff member of TheStreet.